home / stock / mrus / mrus articles

MRUS Articles, Merus N.V.

Stock Information
Company Name: Merus N.V.
Stock Symbol: MRUS
Market: NASDAQ
Website: merus.nl
Menu
MRUS MRUS Quote MRUS Short MRUS News MRUS Articles MRUS Message Board
Get MRUS Alerts

News, Short Squeeze, Breakout and More Instantly...
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer | Benzinga

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) (Merus, the Company, we, or our), a cl...
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting | Benzinga

UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) (Merus, the Company, we, or our), a cl...

Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference | Benzinga

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company deve...

Crude Oil Rises 1%; Verastem Shares Slide | Benzinga

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.12% to 39,112.74...
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday's session after the company reported worse-than-expected first-quarter revenue. NetEa...

Nasdaq Gains 1%; Intuit Shares Plunge | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday. The Dow traded up 0.25% to 39,163.18 while...

Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were higher, with the Nasdaq Composite gaining around 80 points on Friday. Shares of Deckers Outdoor Corporation (NYSE:DECK) rose sharp...
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting | Benzinga

-   60% response rate observed among 10 evaluable patients -   Favorable safety profile in 26 patients enrolled as of the abstract cutoff date...

Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference | Benzinga

UTRECHT, The Netherlands and CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company de...

Merus to Participate in Upcoming Investor Conferences | Benzinga

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company dev...
Next 10